Cartesian Therapeutics In... (RNAC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
19.13
1.11 (6.16%)
At close: Jan 15, 2025, 3:59 PM
19.50
1.93%
After-hours Jan 15, 2025, 04:08 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
PE Ratio | -0.46 | 4.62 | -14.51 | -4.45 | -1.96 | -0.91 | -3.07 | -4.97 | -10.37 | -13.99 |
PS Ratio | 3.91 | 1.48 | 4.38 | 18.48 | 16.24 | 65.95 | 967.97 | 22.27 | 43.44 | 59.26 |
PB Ratio | -0.23 | 1.74 | 16.55 | -17.03 | 12.91 | -10.99 | 3.87 | 3.27 | 12.44 | -2.05 |
P/FCF Ratio | -1.98 | -4.98 | -6.06 | 9.00 | -2.11 | -0.99 | -3.8 | -8.88 | -11.05 | -13.95 |
P/OCF Ratio | -1.99 | -5.17 | -6.17 | 8.79 | -2.11 | -1.01 | -3.85 | -9.14 | -11.62 | -14.2 |
OCF/S Ratio | -1.97 | -0.29 | -0.71 | 2.10 | -7.7 | -65.52 | -251.39 | -2.44 | -3.74 | -4.17 |
Debt / Equity Ratio | -0.02 | 0.40 | 1.57 | -1.96 | 2.30 | -3.95 | 0.41 | 0.22 | 0.56 | -0.08 |
Quick Ratio | 1.33 | 5.91 | 2.00 | 1.84 | 2.77 | 1.20 | 8.99 | 6.33 | 5.34 | 2.07 |
Current Ratio | 1.33 | 5.91 | 2.00 | 1.86 | 2.77 | 1.20 | 8.99 | 6.33 | 5.34 | 2.07 |
Asset Turnover | 0.09 | 0.67 | 0.53 | 0.10 | 0.07 | 0.02 | 0.00 | 0.09 | 0.14 | 0.14 |
Interest Coverage | -30.5 | 4.80 | -1.62 | -36.52 | -34.53 | -43.52 | -52.89 | -27.67 | -26.69 | -27.9 |
Return on Equity (ROE) | 0.50 | 0.38 | -1.14 | 3.83 | -6.59 | 12.06 | -1.26 | -0.66 | -1.2 | 0.15 |
Return on Assets (ROA) | -0.72 | 0.21 | -0.16 | -0.42 | -0.56 | -1.47 | -0.65 | -0.41 | -0.59 | -0.58 |
Return on Capital (ROIC) | -0.36 | 0.10 | -0.05 | -0.68 | -0.81 | -6.96 | -0.71 | -0.46 | -0.71 | -1.18 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 94.03% | 98.16% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Net Profit Margin | -844.91% | 31.94% | -30.19% | -414.99% | -828.97% | -7.24K% | -31.56K% | -447.98% | -418.8% | -423.68% |
Pretax Profit Margin | -917.97% | 31.39% | -11.43% | -414.99% | -828.97% | -7.24K% | -31.56K% | -447.98% | -418.8% | -423.68% |
Operating Profit Margin | -332.32% | 13.12% | -5.4% | -342.36% | -785.61% | -7.20K% | -30.81K% | -428.92% | -420.96% | -506.55% |
FCF Margin | -197.53% | -29.64% | -72.25% | 205.25% | -771.03% | -6.65K% | -25.49K% | -250.76% | -393.05% | -424.77% |
EBITDA Margin | -903.95% | 35.96% | -6.06% | -395.21% | -775.86% | -6.96K% | -30.61K% | -422.55% | -385.66% | -377.11% |